Dealing with FDA Form 483 and Warning Letter Findings | BioBoston Consulting
Food and Drug Administration (FDA) oversee strict regulations over life science companies in the United States, that is why it is necessary to be on
Food and Drug Administration (FDA) oversee strict regulations over life science companies in the United States, that is why it is necessary to be on
Common FDA Inspection Pitfalls: How to Avoid Them? Compliance within the life science industry is a vital part of business operations. The US FDA is
Best Practices in Change Control for mRNA Immunotherapy Manufacturing Understand the importance of change control for mRNA immunotherapy manufacturing — and best practices for fluent
How can you give your team the space to become the backbone of compliance? In life sciences industry which is complex and heavily regulated, precision
From Concept to IND Submissions: A Detailed Roadmap to Regulatory Approval The Investigational New Drug (IND) application is a crucial regulatory submission required to begin
The BLA Submission Process Explained A Biologics License Application is an extensive record that contains all the relevant information about the biologic product, its manufacturing
The world of pharmaceuticals, biotechnology, and medical devices moves at a fast pace. Therefore, keep yourself updated on ever-evolving regulations and industry best practices is
The U.S. Food and Drug Administration (FDA) recently released a new guidance document on premarket submissions for device software functions. The guidance “Content of Premarket
The FDA approval process can be challenging, luckily you have us to help you make your way through the regulatory wilderness of biologics. Biologics to
The quality, safety, and efficacy of pharmaceutical products are highly regulated by Good Manufacturing Practices (GMPs) throughout the lifecycle of product manufacture. The guidelines establish